Leonteq Securities AG’s Autolus Therapeutics AUTL Stock Holding History

Leonteq Securities AG’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Hold	100,000	–	–	0.01%	614
2026 Q1	$138K	Hold	100,000	–	–	0.01%	674
2025 Q4	$199K	Hold	100,000	–	–	0.01%	669
2025 Q3	$163K	Hold	100,000	–	–	﹤0.01%	637
2025 Q2	$228K	Buy	100,000 +25,000	+33%	+$41.3K	0.01%	543
2025 Q1	$116K	Sell	75,000 -25,000	-25%	-$50.8K	0.01%	665
2024 Q4	$235K	Buy	100,000 +75,000	+300%	+$254K	0.02%	502
2024 Q3	$90.8K	Hold	25,000	–	–	0.01%	640
2024 Q2	$87K	Hold	25,000	–	–	0.01%	650
2024 Q1	$160K	Sell	25,000 -25,000	-50%	-$156K	0.01%	545
2023 Q4	$322K	Hold	50,000	–	–	0.02%	405
2023 Q3	$117K	Sell	50,000 -25,000	-33%	-$71.2K	0.01%	620
2023 Q2	$179K	Sell	75,000 -25,000	-25%	-$59.3K	0.01%	564
2023 Q1	$184K	Hold	100,000	–	–	0.01%	546
2022 Q4	$190K	Buy	+100,000	New	+$253K	0.01%	557

Other funds holding AUTL

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Leonteq Securities AG's AUTL Position: Q2 2026 in Review

Leonteq Securities AG held its Autolus Therapeutics (AUTL) position steady in Q2 2026 at 100,000 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #614.

Leonteq Securities AG first reported a position in AUTL in Q4 2022 and has held it in 15 quarters since. The position peaked at $322K in Q4 2023. 83 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

Leonteq Securities AG held 100,000 shares of Autolus Therapeutics worth $160K as of Q2 2026.
Leonteq Securities AG left its Autolus Therapeutics share count unchanged in Q2 2026.
Autolus Therapeutics made up 0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #614 holding.
Leonteq Securities AG first reported a position in Autolus Therapeutics in Q4 2022 and has held it in 15 quarters since.
Leonteq Securities AG's Autolus Therapeutics position peaked at $322K in Q4 2023.
83 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.